Cotellic (cobimetinib) Tablets, 20 mg, 63 count bottle, Rx Only, Made in Switzerland. Distributed by Genentech USA, Inc., South Francisco, CA. 94080, NDC 50242-717-01,UPC 3 50242-717-01.

Class I - Dangerous

What Should You Do?

  1. Check if you have this product:
    B1009MC, B1009M9, B1009MA; Exp. 02/18 B1009MT 02/19
  2. Do not eat it: Even if it looks and smells fine, do not consume this product.
  3. Throw it away or return it: You can return the product to the store for a full refund.
  4. Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
  5. Report problems: Report any issues to the FDA's Safety Reporting Portal.

⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.

Recall Details

Company:
Genentech Inc.
Reason for Recall:
Superpotent Drug: An oversized tablet was found in a bottle.
Classification:
Class I - Dangerous

Dangerous or defective products that predictably could cause serious health problems or death.

Status:
terminated

Product Information

Full Description:

Cotellic (cobimetinib) Tablets, 20 mg, 63 count bottle, Rx Only, Made in Switzerland. Distributed by Genentech USA, Inc., South Francisco, CA. 94080, NDC 50242-717-01,UPC 3 50242-717-01.

Product Codes/Lot Numbers:

B1009MC, B1009M9, B1009MA; Exp. 02/18 B1009MT 02/19

Distribution:

Distributed in: NJ, IL

Official Source

Always verify recall information with the official FDA source:

View on FDA.gov

FDA Recall Number: D-0648-2017

Related Recalls

Defective Delivery System: Commercial implants do not meet the filed specification for the intended use, a few patients have experienced an issue with the implants that renders it non-functioning.

Oct 18, 2022 Prescription Drugs Nationwide View Details →